---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-050533"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2026-11-06T22:25:10+00:00"
generated_at: "2026-11-06T22:26:09.241388+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals plans up to $10M Series D preferred Reg A offering; annual meeting set for Dec 30

## Summary
- Series B holder (all 50 shares) consented Nov 2, 2026 to 8% Series D Convertible Cumulative Preferred; up to 1,000,000 shares at $10.00 each via Regulation A offering.
- Neither the Series B Amendment nor the Series D certificate of designations has been filed with the Texas Secretary of State; neither is effective and the Company may not proceed.
- Series B Amendment recognizes Series D's senior dividend and liquidation rights and is limited to approving the Series D designation only.
- Combined 2025 and 2026 annual meeting set for Dec 30, 2026 at Dallas offices; record date Nov 12, 2026; shareholder proposals due Nov 16, 2026.
- No sales in the contemplated Regulation A offering will occur before the SEC qualifies the Form 1-A offering statement.

## SEC filing metadata
- accession: 0001493152-26-050533
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2026-11-06T22:25:10+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.07, 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315226050533/0001493152-26-050533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315226050533/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-050533
- JSON: https://secwatch.observer/filing/0001493152-26-050533.json
- Plain text: https://secwatch.observer/filing/0001493152-26-050533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.